BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2015
View Archived Issues
Dendritic cell vaccination induces tumor-specific immune responses
Read More
China Food and Drug Administration accepts clinical trial application for sirotinib
Read More
ONO-7750512 shows potent antithrombotic effect without increasing bleeding risk
Read More
Bristol-Myers Squibb provides update on pipeline for fibrotic diseases
Read More
Aerpio Therapeutics reports data from phase IIa study of AKB-9778 in DME
Read More
CytoDyn reports evidence of HIV suppression with PRO-140
Read More
Pharmacological profile a novel FXIa inhibitor from Sumitomo Dainippon presented
Read More
Initiation of phase II study of Ad26.ZEBOV and MVA-BN-Filo Ebola prime-boost vaccine regimen
Read More
Esteve discloses sigma1-receptor ligands
Read More
Wee1-like protein kinase inhibitors in early development at Almac Discovery
Read More
A*STAR patent describes Wnt signaling inhibitors
Read More
BTK inhibitors described in Merck & Co. patent
Read More
IRM divulges antiparasitic agents
Read More
Santen launches Ikervis in Germany for keratitis in dry eye disease
Read More
FDA grants orphan drug designation to DPX-Survivac for ovarian cancer
Read More
ValiRx announces plans for phase II trial of VAL-401
Read More
Treeway and collaborators receive grant to develop edaravone for ALS
Read More
Nanocarrier formulation improves delivery of CsA to the eye
Read More
FDA gives orphan drug designation to Kevetrin for ovarian cancer
Read More
AB Science initiates phase II/III trial of masitinib in ovarian cancer
Read More
Cerenis releases results from LOCATION study of CER-001 in atherosclerotic disease
Read More
AstraZeneca enters into commercialization option agreement for benralizumab in Japan
Read More
Celgene to acquire Receptos
Read More
ErepoXen increases hemoglobin levels to therapeutic range in phase II trial
Read More
Swedish Orphan Biovitrum exercises Alprolix opt-in right
Read More